Home/Filings/4/0001209191-22-059154
4//SEC Filing

Niihara Yutaka 4

Accession 0001209191-22-059154

CIK 0000822370other

Filed

Nov 30, 7:00 PM ET

Accepted

Dec 1, 1:35 PM ET

Size

14.0 KB

Accession

0001209191-22-059154

Insider Transaction Report

Form 4
Period: 2022-11-03
Niihara Yutaka
DirectorChairman and CEO10% Owner
Transactions
  • Purchase

    Common stock, $0.001 par value

    2022-11-03$0.45/sh+2,500$1,12511,990,757 total
  • Purchase

    Common stock, $0.001 par value

    2022-11-28$0.35/sh+5,000$1,75012,003,257 total
  • Purchase

    Common stock, $0.001 par value

    2022-11-30$0.41/sh+22,900$9,38912,040,857 total
  • Purchase

    Common stock, $0.001 par value

    2022-11-04$0.45/sh+7,500$3,37511,998,257 total
  • Purchase

    Common stock, $0.001 par value

    2022-11-29$0.38/sh+14,700$5,58612,017,957 total
Holdings
  • Common stock, $0.001 par value

    (indirect: By Soomi Niihara)
    63,000
  • Common stock, $0.001 par value

    (indirect: By Hope International Hospice, Inc.)
    92,794
Footnotes (5)
  • [F1]The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife.
  • [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4.
  • [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.36 to $0.40, inclusive.
  • [F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.40 to $0.44, inclusive.
  • [F5]Hope International Hospice, Inc. is a California corporation of which Dr. Niihara and his wife are the sole shareholders and directors.

Issuer

Emmaus Life Sciences, Inc.

CIK 0000822370

Entity typeother

Related Parties

1
  • filerCIK 0001517691

Filing Metadata

Form type
4
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 1:35 PM ET
Size
14.0 KB